3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Lymphoid
1
Conditions
Breast Neoplasms
4
Neoplasms
3
Anxiety Disorders
3
Motor Activity
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma
2
Vomiting
1
Triple Negative Breast Neoplasms
1
Treatment Adherence and Compliance
1
Sclerosteosis
1
Recurrence
1
Periodontitis
1
Periodontal Diseases
1
Patient Compliance
1
Osteoporosis, Postmenopausal
1
Obesity
1
Nausea
1
Lymphedema
1
Liver Cirrhosis
1
Leukemia, Promyelocytic, Acute
1
Inflammation
1
Gastrointestinal Neoplasms
1
Feeding Behavior
1
Dendritic Cell Sarcoma, Interdigitating
1
Colorectal Neoplasms
1
Carcinoma, Hepatocellular
1
Interventions
Cyclophosphamide
64
fludarabine phosphate
37
Peripheral Blood Stem Cell Transplantation
30
Cyclosporine
30
Radiotherapy
28
Mycophenolic Acid
28
Filgrastim
28
Busulfan
28
Whole-Body Irradiation
26
Antilymphocyte Serum
24
Melphalan
19
Etoposide
19
Tacrolimus
16
Methotrexate
16
Cord Blood Stem Cell Transplantation
16
Methylprednisolone
15
Rituximab
14
Thiotepa
10
Cytarabine
10
Vincristine
8
Prednisone
8
Doxorubicin
8
Carboplatin
7
fludarabine
5
Sirolimus
5
sargramostim
4
glofitamab
4
aldesleukin
4
Therapeutics
4
Leucovorin
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Dendritic Cell Sarcoma, Interdigitating
×
Weights and Measures
×
Clear all
NCT04113226
2023-02-08
Relyage
Centre Hospitalier Universitaire, Amiens
Phase 2
Unknown
114 enrolled